• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SHIRAKAWA OLYMPUS CO., LTD. VISERA CYSTO-NEPHRO VIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SHIRAKAWA OLYMPUS CO., LTD. VISERA CYSTO-NEPHRO VIDEOSCOPE Back to Search Results
Model Number CYF-VA2
Medical Device Problem Code Failure to Clean Adequately (4048)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device evaluation is ongoing.Should additional relevant information become available, a supplemental report will be submitted.
 
Event or Problem Description
It was observed during the device inspection, that the cysto nephro videoscope exhibited foreign objects inside the forceps channel.There were no reports of patient involvement.
 
Additional Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacture's (lm) review of the customer cleaning disinfection and sterilization (cds) processes, and the lms final investigation.The device was returned for evaluation where the reported event was identified.Based on the results of the investigation, the foreign material could not be specified and a definitive root cause cannot be identified.Physical damage was not found at the foreign material residue points and from the information obtained, it is unclear whether the reprocessing was carried out in accordance with the ifu, so the cause of the foreign material remaining could not be determined.Based on the facts found in the investigation, we surmised that the foreign material might have remained because reprocessing was deviated from the procedures written in the instruction manual.A review of the device history record found no deviations that could have caused or contributed to the reported issue.The subject event can be detected and prevented by implementation in accordance with the below ifu.As to the reprocessing procedures of the subject device, we checked the contents written in the instruction manual and found the following chapters.Residue of the foreign material might be prevented by following the chapters below.Chapter 5 reprocessing: general policy.Chapter 6 compatible reprocessing methods and chemical agents.Chapter 7 cleaning, disinfection, and sterilization procedures.Chapter 8 compatible endoscope reprocessor.Olympus will continue to monitor the field performance of this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VISERA CYSTO-NEPHRO VIDEOSCOPE
Common Device Name
CYSTO-NEPHRO VIDEOSCOPE
Manufacturer (Section D)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8 061
JA  961-8061
Manufacturer (Section G)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key20634582
Report Number3002808148-2024-10882
Device Sequence Number7470989
Product Code FAJ
UDI-Device Identifier04953170339455
UDI-Public04953170339455
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K133538
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 11/25/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Model NumberCYF-VA2
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/20/2024
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/22/2024
Supplement Date Received by Manufacturer11/20/2024
Initial Report FDA Received Date11/07/2024
Supplement Report FDA Received Date11/25/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/12/2014
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Patient SexUnknown
-
-